SCHEMBL10690731

SCHEMBL10690731

Cn1c(Cl)cnc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2305939 0.76
SCHEMBL2305935 0.74
SCHEMBL13314676 0.70 ALDH1A1 (0.37)
SCHEMBL13334948 0.70
SCHEMBL13349088 0.70
SCHEMBL13361823 0.70
SCHEMBL23046254 0.69 HPGD (0.36)
SCHEMBL13066830 0.69
SCHEMBL31378541 0.69 ALDH1A1 (0.38)
SCHEMBL22997901 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115413275-A Substituted 1,1 , -biphenyl compounds and methods of use thereof 爱彼特生物制药公司 2022-11-29 CN disclosed
WO-2017168454-A2 NOVEL COMPOUNDS AS BTK INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) 2017-10-05 WO disclosed
WO-2017134685-A2 NOVEL HYDRAZINO COMPOUNDS AS BTK INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) 2017-08-10 WO disclosed
US-4762830-A 5-(azolyloxyphenylcarbamoyl)barbituric acid derivatives as anthelmintics CIBA-GEIGY CORPORATION (US) 1988-08-09 US disclosed